Lupus nephritis (LN) is among the most serious complications of systemic lupus erythematosus (SLE), which causes significant morbidity and mortality. Renalase is a novel, kidney-secreted cytokine-like protein that promotes cell survival. Here, we aimed to investigate the relationship of serum renalase levels with LN and its role in the disease progression of LN.For this cross-sectional study, 67 LN patients and 35 healthy controls were enrolled. Seventeen active LN patients who received standard therapies were followed up for six months. Disease activity was determined by the SLE Disease Activity-2000 (SLEDAI-2K) scoring system and serum renalase amounts were determined by ELISA. Predictive value of renalase for disease activity was assesse...
Background: Lupus nephritis (LN) often lead to end-stage renal disease in systemic lupus erythematos...
Aim: To assess association between urinary levels of adiponectin and severity of renal involvement i...
Approximately 30% of patients with the systemic autoimmune/inflammatory disorder systemic lupus eryt...
Lupus nephritis (LN) is among the most serious complications of systemic lupus erythematosus (SLE), ...
Systemic lupus erythematosus (SLE) is a chronic, relapsing, polysystemic autoimmune disease with var...
Background. Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease that common...
The objective of this study is to evaluate the correlation between antinucleosome antibodies and ren...
AbstractBackgroundLupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus (S...
Lupus Nephritis (LN) develops in more than half of the Systemic Lupus Erythematous (SLE) patients. H...
Neutrophil gelatinase-associated lipocalin (NGAL) has been demonstrated to be a novel biomarker in a...
Introduction: Lupus nephritis (LN) is a severe and frequent manifestation of systemic lupus erythema...
Lupus nephritis is one of the most severe manifestations of systemic lupus erythematous. Renal invol...
BackgroundManagement of lupus nephritis (LN) would be greatly aided by the discovery of biomarkers t...
Background: Renalase is an enzyme and a cytokine involved in cell survival. Since its discovery, ass...
ABSTRACT. Objective. Vascular cell adhesion molecule-1 (VCAM-1), an adhesion molecule, is involved i...
Background: Lupus nephritis (LN) often lead to end-stage renal disease in systemic lupus erythematos...
Aim: To assess association between urinary levels of adiponectin and severity of renal involvement i...
Approximately 30% of patients with the systemic autoimmune/inflammatory disorder systemic lupus eryt...
Lupus nephritis (LN) is among the most serious complications of systemic lupus erythematosus (SLE), ...
Systemic lupus erythematosus (SLE) is a chronic, relapsing, polysystemic autoimmune disease with var...
Background. Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease that common...
The objective of this study is to evaluate the correlation between antinucleosome antibodies and ren...
AbstractBackgroundLupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus (S...
Lupus Nephritis (LN) develops in more than half of the Systemic Lupus Erythematous (SLE) patients. H...
Neutrophil gelatinase-associated lipocalin (NGAL) has been demonstrated to be a novel biomarker in a...
Introduction: Lupus nephritis (LN) is a severe and frequent manifestation of systemic lupus erythema...
Lupus nephritis is one of the most severe manifestations of systemic lupus erythematous. Renal invol...
BackgroundManagement of lupus nephritis (LN) would be greatly aided by the discovery of biomarkers t...
Background: Renalase is an enzyme and a cytokine involved in cell survival. Since its discovery, ass...
ABSTRACT. Objective. Vascular cell adhesion molecule-1 (VCAM-1), an adhesion molecule, is involved i...
Background: Lupus nephritis (LN) often lead to end-stage renal disease in systemic lupus erythematos...
Aim: To assess association between urinary levels of adiponectin and severity of renal involvement i...
Approximately 30% of patients with the systemic autoimmune/inflammatory disorder systemic lupus eryt...